FDA Inspection 730949 — Novo Nordisk A/S
The FDA completed an inspection of Novo Nordisk A/S on February 8, 2011 in Kalundborg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 8, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kalundborg (Denmark)